Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. [electronic resource] by
- Vogelzang, Nicholas J
- Rusthoven, James J
- Symanowski, James
- Denham, Claude
- Kaukel, E
- Ruffie, Pierre
- Gatzemeier, Ulrich
- Boyer, Michael
- Emri, Salih
- Manegold, Christian
- Niyikiza, Clet
- Paoletti, Paolo
Producer: 20030814
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 21
Availability: No items available.
|
|
7.
|
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy. [electronic resource] by
- Niyikiza, Clet
- Baker, Sharyn D
- Seitz, David E
- Walling, Jackie M
- Nelson, Katrina
- Rusthoven, James J
- Stabler, Sally P
- Paoletti, Paolo
- Calvert, A Hilary
- Allen, Robert H
Producer: 20030113
In:
Molecular cancer therapeutics vol. 1
Availability: No items available.
|
|
8.
|
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. [electronic resource] by
- Scagliotti, Giorgio V
- Shin, Dong-M
- Kindler, Hedy L
- Vasconcelles, Michael J
- Keppler, Uwe
- Manegold, Christian
- Burris, Howard
- Gatzemeier, Ulrich
- Blatter, Johannes
- Symanowski, James T
- Rusthoven, James J
Producer: 20030430
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 21
Availability: No items available.
|